Nanobiofab
2 known investors
NanoBioFab develops AI-powered nanosensor technology for rapid, non-invasive detection of pathogens through their gaseous signatures in clinical settings. The technology targets hospitals and enterprise healthcare systems for applications in orthopedics, wound care, urology, and pulmonology.
Founders & leadership
XL
Xiaonao Liu, PhDinFounder Β· Chief Executive Officer
Investors Β· 2
Non-dilutive funding Β· 4 SBIR/STTR awards
Federal grants β no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of DefenseDefense Health Program | Phase II | 2023 | $1.6M |
| Department of DefenseDefense Health Program | Phase II | 2023 | $1.1M |
| Department of DefenseDefense Health Program | Phase I | 2022 | $250K |
| Department of DefenseDefense Health Program | Phase I | 2020 | $250K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts β non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Nanobiofab do?
- NanoBioFab develops AI-powered nanosensor technology for rapid, non-invasive detection of pathogens through their gaseous signatures in clinical settings. The technology targets hospitals and enterprise healthcare systems for applications in orthopedics, wound care, urology, and pulmonology.
- Who founded Nanobiofab?
- Nanobiofab was founded by Xiaonao Liu, PhD.
- Who are Nanobiofab's investors?
- Nanobiofab's investors include Maryland TEDCO, TEDCO.